Cargando…
Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072985/ http://dx.doi.org/10.1186/2049-3002-2-S1-P14 |
_version_ | 1782323048713551872 |
---|---|
author | Telang, Sucheta O’Neal, Julie Tapolsky, Gilles Clem, Brian Kerr, Alan Imbert-Ferndandez, Yoannis Chesney, Jason |
author_facet | Telang, Sucheta O’Neal, Julie Tapolsky, Gilles Clem, Brian Kerr, Alan Imbert-Ferndandez, Yoannis Chesney, Jason |
author_sort | Telang, Sucheta |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4072985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40729852014-07-01 Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib Telang, Sucheta O’Neal, Julie Tapolsky, Gilles Clem, Brian Kerr, Alan Imbert-Ferndandez, Yoannis Chesney, Jason Cancer Metab Poster Presentation BioMed Central 2014-05-28 /pmc/articles/PMC4072985/ http://dx.doi.org/10.1186/2049-3002-2-S1-P14 Text en Copyright © 2014 Telang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Telang, Sucheta O’Neal, Julie Tapolsky, Gilles Clem, Brian Kerr, Alan Imbert-Ferndandez, Yoannis Chesney, Jason Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib |
title | Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib |
title_full | Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib |
title_fullStr | Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib |
title_full_unstemmed | Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib |
title_short | Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib |
title_sort | discovery of a pfkfb3 inhibitor for phase i trial testing that synergizes with the b-raf inhibitor vemurafenib |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072985/ http://dx.doi.org/10.1186/2049-3002-2-S1-P14 |
work_keys_str_mv | AT telangsucheta discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib AT onealjulie discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib AT tapolskygilles discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib AT clembrian discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib AT kerralan discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib AT imbertferndandezyoannis discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib AT chesneyjason discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib |